Alpesh Goyal

ORCID: 0000-0003-0922-5022
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gestational Diabetes Research and Management
  • Diabetes Management and Research
  • Bariatric Surgery and Outcomes
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Diabetes and associated disorders
  • Growth Hormone and Insulin-like Growth Factors
  • Medical Imaging and Pathology Studies
  • Neuroendocrine Tumor Research Advances
  • Pregnancy and preeclampsia studies
  • Parathyroid Disorders and Treatments
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Pituitary Gland Disorders and Treatments
  • Sexual Differentiation and Disorders
  • Adolescent and Pediatric Healthcare
  • Adrenal and Paraganglionic Tumors
  • COVID-19 Clinical Research Studies
  • Cancer, Hypoxia, and Metabolism
  • Pancreatic and Hepatic Oncology Research
  • Adrenal Hormones and Disorders
  • Liver Disease Diagnosis and Treatment
  • Birth, Development, and Health
  • Childhood Cancer Survivors' Quality of Life
  • Diabetes Management and Education
  • Hormonal Regulation and Hypertension
  • Metabolism and Genetic Disorders

All India Institute of Medical Sciences
2012-2025

All India Institute of Medical Sciences Bhopal
2018-2025

Fistulacure
2024

All India Institute of Medical Sciences Raipur
2018-2024

Creative Commons
2022-2023

Kalpavriksh
2020

National Institute of Pathology
2019

University College of Medical Sciences
2018

Max Healthcare
2018

Nethradhama Superspeciality Eye Hospital
2018

Gestational diabetes mellitus (GDM) is a major public health problem, affecting about one in every six pregnancies globally. The guidelines provided by the American Diabetes Association (ADA) on diagnosis and management of hyperglycemia pregnancy are widely followed. We aim to provide critical appraisal recently published ADA guidance document, highlighting its strength limitations with regard GDM.We reviewed recent recommendations for pregnancy. A periodic update keeping emerging evidence,...

10.1007/s13300-020-00865-3 article EN cc-by-nc Diabetes Therapy 2020-06-20

Guidelines recommend screening older people (> 60–65 years) with type 2 diabetes (T2D) for cognitive impairment, as it has implications in the management of diabetes. The Montreal Cognitive Assessment (MoCA) is a sensitive test detection mild impairment (MCI) general population, but its validity T2D not been established. We administered MoCA to patients (age ≥ 60 and controls (no T2D), along culturally validated neuropsychological battery functional activity questionnaire. MCI was defined...

10.1007/s13300-024-01549-y article EN cc-by-nc Diabetes Therapy 2024-03-23

This study aims to evaluate the prevalence of and factors associated with non-alcoholic fatty liver disease (NAFLD) in Indian women prior gestational diabetes mellitus (GDM) diagnosed using International Association Diabetes Pregnancy Study Groups (IADPSG) criteria.This cross-sectional (2018-2019) enrolled without GDM. participants underwent detailed assessments, including relevant medical, obstetric demographic details; 75-g oral glucose tolerance test insulin estimation at 0, 30 120 min;...

10.1111/jdi.13411 article EN cc-by-nc Journal of Diabetes Investigation 2020-09-23

Despite being the most common cause of secondary hypertension, prevalence primary aldosteronism (PA) among patients with young-onset hypertension (YH - age onset <40 years) remains poorly studied.We assessed PA in YH referred for evaluation hypertension.In this prospective, cross-sectional study, 202 YH, visiting endocrine and cardiology clinics All India Institute Medical Sciences, India, were evaluated.Primary was screened by measuring plasma aldosterone concentration (PAC) direct renin...

10.1111/cen.14409 article EN Clinical Endocrinology 2021-01-04

Abstract Background Patients admitted with acute severe ulcerative colitis (ASUC) respond to medical therapy in upto two-third cases but monitoring and early detection of non-response is prime importance prevent colectomy or mortality, through use rescue therapy. This study evaluates the utility ultrasonography (USG) prognostication decision-making for ASUC patients undergoing standardized treatment protocols. USG offers a non-invasive approach assess bowel wall thickening vascularity,...

10.1093/ecco-jcc/jjae190.0849 article EN Journal of Crohn s and Colitis 2025-01-01

Abstract Purpose We aimed to evaluate the prevalence of postpartum diabetes among women with a history overt in pregnancy (ODiP) and compare having gestational mellitus (GDM) normoglycemia pregnancy. Methods have an established longitudinal cohort hyperglycemia (preexisting [PED] [ n = 101], ODiP 92], GDM 643]), ( 183) For this study, we excluded PED invited other eligible fasting state for clinical biochemical evaluation. Results evaluated 918 mean (SD) age 33.6 (5.0) years at median...

10.1111/1753-0407.13461 article EN cc-by Journal of Diabetes 2023-08-30

The coronavirus disease 2019 (COVID-19) outbreak has rapidly crossed international boundaries and placed increasing demands on healthcare facilities worldwide. Patients with diabetes uncontrolled blood glucose levels are at increased risk for poor clinical outcomes in-hospital mortality related to COVID-19. Therefore, achieving good glycaemic control is of paramount importance among hospitalised patients Basal-bolus insulin therapy a safe effective intervention the management hyperglycaemia...

10.1007/s13300-020-00873-3 article EN cc-by-nc Diabetes Therapy 2020-07-18

This case report describes 15-year-old identical twin sisters, who presented to us with features of polycystic ovary syndrome (PCOS). A biochemical workup revealed hyperinsulinemia and androgen excess elevated prolactin levels. The possible etiologies for hyperprolactinemia were excluded a detailed evaluation it was labeled as idiopathic. Considering the fact that could be caused by either insulin resistance or hyperprolactinemia, we decided treat one sister sensitizer metformin other...

10.7759/cureus.3004 article EN Cureus 2018-07-19
Coming Soon ...